Acousti-Celotex Acoustic Tile

Acousti-Celotex acoustic tile was a commercial and industrial ceiling product manufactured by the Celotex Corporation, a building materials company with deep roots in the American construction industry. Like many acoustical ceiling and insulation products sold during the mid-twentieth century, Acousti-Celotex contained asbestos as a functional ingredient. Workers who handled, installed, cut, or disturbed the product during manufacturing, construction, or renovation were placed at risk of asbestos fiber inhalation — a risk that was not adequately disclosed to them at the time. The Celotex Corporation Asbestos Settlement Trust now exists to compensate eligible claimants who developed asbestos-related diseases connected to this and other Celotex products.

Product Description

Acousti-Celotex was marketed as an acoustical ceiling tile designed to reduce sound transmission and improve interior acoustics in commercial, industrial, and institutional buildings. Celotex Corporation positioned the product within a broad portfolio of building materials that included insulation board, roof decking, and other construction products. The “Celotex” name itself became closely associated with fiberboard and acoustical ceiling systems throughout much of the twentieth century, and Acousti-Celotex represented one of the company’s entries into the acoustical tile segment.

The tile was used widely in industrial and commercial construction settings, where its combination of sound-dampening properties and fire resistance made it a practical specification choice for architects and contractors. Buildings constructed or renovated during the decades when asbestos-containing building materials were commonplace — generally from the mid-twentieth century through the late 1970s and into the early 1980s — may still contain Acousti-Celotex or similar Celotex acoustical products in place today.

The Celotex Corporation, headquartered in Tampa, Florida, operated as a significant manufacturer and distributor of construction materials. The company ultimately filed for bankruptcy protection in part due to the substantial volume of asbestos personal injury claims it faced, which led to the creation of the Celotex Corporation Asbestos Settlement Trust to resolve present and future claims.

Asbestos Content

Acousti-Celotex acoustic tile contained asbestos as a component of its formulation. Asbestos was incorporated into acoustical ceiling tile products during this era for several practical reasons: it provided fire resistance, improved structural integrity, and helped bind the tile’s fibrous matrix together. These properties made asbestos an attractive additive for manufacturers competing in the commercial building materials market, where fire codes and performance specifications drove product development.

Asbestos-containing ceiling tiles are addressed under the Asbestos Hazard Emergency Response Act (AHERA) and related EPA regulations, which classify such materials as regulated asbestos-containing material (RACM) when friable or when they have the potential to release fibers during disturbance. Once installed and left undisturbed, asbestos-containing ceiling tiles may pose a lower immediate risk; however, any activity that involves cutting, breaking, sanding, drilling, or demolishing such tiles generates respirable asbestos fibers. Renovation and demolition activities are among the most hazardous contexts in which legacy asbestos-containing products like Acousti-Celotex are encountered today.

How Workers Were Exposed

Industrial workers represent the primary occupational population documented in connection with Acousti-Celotex acoustic tile exposure. Exposure pathways were varied and depended on the specific role a worker performed in relation to the product.

Manufacturing workers employed at facilities that produced Acousti-Celotex or that processed raw asbestos for use in such products faced direct and sustained fiber exposure. Raw asbestos was handled in bulk, mixed into product formulations, and processed in ways that generated significant airborne dust. Workers at these facilities often had no respiratory protection and were not informed of the hazards associated with asbestos inhalation.

Construction and installation workers who handled Acousti-Celotex on job sites encountered exposure when tiles were cut to fit dimensions, mechanically fastened, or trimmed during installation. Cutting acoustical tile with hand saws or power tools releases fiber-containing dust that, without proper controls, becomes airborne and is readily inhaled.

Renovation and demolition workers face ongoing exposure risks when buildings containing legacy Acousti-Celotex tile undergo modification or teardown. Removing, breaking, or disturbing in-place asbestos-containing ceiling tile generates fiber release. OSHA regulations at 29 CFR 1926.1101 (construction) and 29 CFR 1910.1001 (general industry) establish permissible exposure limits and required work practices for asbestos, including requirements for wetting, containment, and respiratory protection during removal.

Bystander and secondary exposure is also documented in asbestos litigation generally: workers in adjacent trades — electricians, pipefitters, painters, and others working in the same spaces where ceiling tiles were being cut or removed — could inhale fibers without ever directly handling the product themselves.

The diseases associated with occupational asbestos exposure include mesothelioma (a cancer of the lining of the lungs, abdomen, or heart), lung cancer, asbestosis (a progressive scarring of lung tissue), and other asbestos-related conditions. These diseases typically have latency periods of 20 to 50 years between initial exposure and diagnosis, meaning workers exposed to Acousti-Celotex decades ago may only now be receiving diagnoses.

The Celotex Corporation Asbestos Settlement Trust was established following the Celotex Corporation’s bankruptcy proceedings, which were driven substantially by the volume of asbestos personal injury claims the company faced. The Trust was created specifically to provide compensation to individuals who suffered asbestos-related harm from Celotex Corporation products, including Acousti-Celotex acoustic tile.

Trust Fund Filing Eligibility

Claimants who can document occupational or other qualifying exposure to Acousti-Celotex or other Celotex Corporation asbestos-containing products, and who have received a diagnosis of an asbestos-related disease, may be eligible to file a claim with the Celotex Corporation Asbestos Settlement Trust. Eligibility generally requires:

  • A qualifying medical diagnosis (mesothelioma, lung cancer, asbestosis, or other recognized asbestos-related condition)
  • Documentation of exposure to a Celotex Corporation product
  • Evidence establishing the exposure occurred within the applicable timeframe

Typical Claim Categories

The Trust processes claims across standard asbestos disease categories, which typically include:

  • Mesothelioma — generally the highest-priority and highest-value claim category
  • Lung cancer — with additional criteria related to asbestos exposure and smoking history
  • Asbestosis and other non-malignant conditions — based on documented medical findings and exposure history

Claims must be submitted in accordance with the Trust’s Distribution Procedures, and claimants may elect to accept the Trust’s scheduled payment offer or pursue an individual review process.

Additional Legal Avenues

In addition to filing with the Celotex Corporation Asbestos Settlement Trust, individuals with asbestos-related diseases linked to Acousti-Celotex exposure may have claims against other parties in the chain of distribution or against multiple trusts if exposure to other manufacturers’ products is also documented. An attorney experienced in asbestos litigation can evaluate the full scope of a potential claim.

Workers and family members who believe they were exposed to Acousti-Celotex acoustic tile should consult with a qualified asbestos attorney to assess their eligibility and pursue available remedies through the Trust and the broader civil justice system.